BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 26946358)

  • 1. The prion protein selectively binds to and modulates the content of purinergic receptor P2X4R.
    Carneiro MV; Americo TA; Guimarães MZ; Linden R
    Biochem Biophys Res Commun; 2016 Apr; 472(2):293-8. PubMed ID: 26946358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Mechanism of the Misfolding and Oligomerization of the Prion Protein: Current Understanding and Its Implications.
    Singh J; Udgaonkar JB
    Biochemistry; 2015 Jul; 54(29):4431-42. PubMed ID: 26171558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular prion protein co-localizes with nAChR beta4 subunit in brain and gastrointestinal tract.
    Petrakis S; Irinopoulou T; Panagiotidis CH; Engelstein R; Lindstrom J; Orr-Urtreger A; Gabizon R; Grigoriadis N; Sklaviadis T
    Eur J Neurosci; 2008 Feb; 27(3):612-20. PubMed ID: 18279314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rdj2, a J protein family member, interacts with cellular prion PrP(C).
    Beck KE; Kay JG; Braun JE
    Biochem Biophys Res Commun; 2006 Aug; 346(3):866-71. PubMed ID: 16774738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PrP(C) signalling in neurons: from basics to clinical challenges.
    Hirsch TZ; Hernandez-Rapp J; Martin-Lannerée S; Launay JM; Mouillet-Richard S
    Biochimie; 2014 Sep; 104():2-11. PubMed ID: 24952348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Biological Function of the Prion Protein: A Cell Surface Scaffold of Signaling Modules.
    Linden R
    Front Mol Neurosci; 2017; 10():77. PubMed ID: 28373833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular prion protein signaling in serotonergic neuronal cells.
    Mouillet-Richard S; Schneider B; Pradines E; Pietri M; Ermonval M; Grassi J; Richards JG; Mutel V; Launay JM; Kellermann O
    Ann N Y Acad Sci; 2007 Jan; 1096():106-19. PubMed ID: 17405922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decoding the function of the N-terminal tail of the cellular prion protein to inspire novel therapeutic avenues for neurodegenerative diseases.
    Iraci N; Stincardini C; Barreca ML; Biasini E
    Virus Res; 2015 Sep; 207():62-8. PubMed ID: 25456402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcellular distribution of the prion protein in sickness and in health.
    Godsave SF; Peters PJ; Wille H
    Virus Res; 2015 Sep; 207():136-45. PubMed ID: 25683509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic molecules and endogenous ligands regulate the interaction between brain cellular prion protein (PrPC) and metabotropic glutamate receptor 5 (mGluR5).
    Haas LT; Kostylev MA; Strittmatter SM
    J Biol Chem; 2014 Oct; 289(41):28460-77. PubMed ID: 25148681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards cellular receptors for prions.
    Lee KS; Linden R; Prado MA; Brentani RR; Martins VR
    Rev Med Virol; 2003; 13(6):399-408. PubMed ID: 14625887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping of possible prion protein self-interaction domains using peptide arrays.
    Rigter A; Langeveld JP; Timmers-Parohi D; Jacobs JG; Moonen PL; Bossers A
    BMC Biochem; 2007 Apr; 8():6. PubMed ID: 17430579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between the cellular prion (PrPC) and the 2P domain K+ channel TREK-1 protein.
    Azzalin A; Ferrara V; Arias A; Cerri S; Avella D; Pisu MB; Nano R; Bernocchi G; Ferretti L; Comincini S
    Biochem Biophys Res Commun; 2006 Jul; 346(1):108-15. PubMed ID: 16750514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PrP(C) association with lipid rafts in the early secretory pathway stabilizes its cellular conformation.
    Sarnataro D; Campana V; Paladino S; Stornaiuolo M; Nitsch L; Zurzolo C
    Mol Biol Cell; 2004 Sep; 15(9):4031-42. PubMed ID: 15229281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neurochemical nature of PrP(c)-containing cells in the rat brain.
    Moleres FJ; Velayos JL
    Brain Res; 2007 Oct; 1174():143-51. PubMed ID: 17854776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct effects of Cu2+-binding on oligomerization of human and rabbit prion proteins.
    Lin K; Yu Z; Yu Y; Liao X; Huang P; Guo C; Lin D
    Acta Biochim Biophys Sin (Shanghai); 2015 Oct; 47(10):842-50. PubMed ID: 26350098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular prion protein interaction with vitronectin supports axonal growth and is compensated by integrins.
    Hajj GN; Lopes MH; Mercadante AF; Veiga SS; da Silveira RB; Santos TG; Ribeiro KC; Juliano MA; Jacchieri SG; Zanata SM; Martins VR
    J Cell Sci; 2007 Jun; 120(Pt 11):1915-26. PubMed ID: 17504807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From cell protection to death: may Ca2+ signals explain the chameleonic attributes of the mammalian prion protein?
    Sorgato MC; Bertoli A
    Biochem Biophys Res Commun; 2009 Feb; 379(2):171-4. PubMed ID: 19101513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state.
    Horiuchi M; Caughey B
    EMBO J; 1999 Jun; 18(12):3193-203. PubMed ID: 10369660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synaptic prion protein immuno-reactivity in the rodent cerebellum.
    Haeberlé AM; Ribaut-Barassin C; Bombarde G; Mariani J; Hunsmann G; Grassi J; Bailly Y
    Microsc Res Tech; 2000 Jul; 50(1):66-75. PubMed ID: 10871550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.